ZEVRA THERAPEUTICS, INC. — Director's Dealing 2021

Jun 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2021-06-14

Reporting Person: Mickle Travis C (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-14	Common Stock	P	1500	$14.43	Acquired	119507	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15242	Indirect
Common Stock	9824	Indirect
Common Stock	7701	Indirect
Common Stock	6287	Direct
Common Stock	1341	Indirect
Common Stock	1034	Indirect

Footnotes

F1: Held jointly with Christal M.M. Mickle.

F2: The Reporting Person and Christal M.M. Mickle are the managing members of Mickle Investments, LLC.